BRPI1014571A2 - composições de combinação de lactona macrocíclica, vacinas e processos para produzir as mesmas - Google Patents
composições de combinação de lactona macrocíclica, vacinas e processos para produzir as mesmasInfo
- Publication number
- BRPI1014571A2 BRPI1014571A2 BRPI1014571A BRPI1014571A BRPI1014571A2 BR PI1014571 A2 BRPI1014571 A2 BR PI1014571A2 BR PI1014571 A BRPI1014571 A BR PI1014571A BR PI1014571 A BRPI1014571 A BR PI1014571A BR PI1014571 A2 BRPI1014571 A2 BR PI1014571A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccines
- processes
- producing
- same
- macrocyclic lactone
- Prior art date
Links
- 150000002596 lactones Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ57620109 | 2009-04-14 | ||
| NZ576201 | 2009-04-14 | ||
| NZ57639109 | 2009-04-20 | ||
| NZ576391 | 2009-04-20 | ||
| NZ2010120195 | 2010-10-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1014571A2 true BRPI1014571A2 (pt) | 2016-04-26 |
| BRPI1014571B1 BRPI1014571B1 (pt) | 2021-08-10 |
| BRPI1014571B8 BRPI1014571B8 (pt) | 2022-06-28 |
Family
ID=42981142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014571A BRPI1014571B8 (pt) | 2009-04-14 | 2010-04-14 | Composições de combinação de lactona macrocíclica, vacinas e métodos para produção das mesmas |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8313752B2 (pt) |
| EP (1) | EP2419131B1 (pt) |
| AU (1) | AU2010237070B2 (pt) |
| BR (1) | BRPI1014571B8 (pt) |
| CA (1) | CA2758276C (pt) |
| CO (1) | CO6450627A2 (pt) |
| CY (1) | CY1116630T1 (pt) |
| DK (1) | DK2419131T3 (pt) |
| ES (1) | ES2546480T3 (pt) |
| MX (1) | MX2011010710A (pt) |
| PL (1) | PL2419131T3 (pt) |
| PT (1) | PT2419131E (pt) |
| WO (1) | WO2010120195A1 (pt) |
| ZA (1) | ZA201107324B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011056175A1 (en) | 2009-11-06 | 2011-05-12 | Intervet International B.V. | Methods of immunizing pregnant heifers at three months of gestation |
| HUE028600T2 (en) * | 2010-05-12 | 2016-12-28 | Merial Inc | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
| WO2014098623A1 (en) * | 2012-12-20 | 2014-06-26 | Alleva Animal Health Limited | Injectable eprinomectin formulation and anthelmintic use thereof |
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR20250057155A (ko) | 2017-12-15 | 2025-04-28 | 타르서스 파마수티칼스, 아이엔씨. | 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법 |
| MX2021012188A (es) * | 2019-04-04 | 2022-02-11 | Tarsus Pharmaceuticals Inc | Parasiticidas sistemicos de isoxazolina para el tratamiento o la profilaxis de enfermedades virales y transmitidas por vectores. |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| EP4117657A4 (en) * | 2020-03-13 | 2024-04-24 | Monash University | VIRUS INHIBITION |
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| CN114642632A (zh) * | 2022-02-25 | 2022-06-21 | 河北科技大学 | 一种莫西克汀注射液及其制备方法 |
| WO2023187599A1 (en) * | 2022-03-27 | 2023-10-05 | Didenko Kirill | Methods and bioavailable highly permeable compounds for the treatment of viral diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191413A (en) | 1978-09-11 | 1981-10-19 | Ici Australia Ltd | Anthelmintic and anticlostridial composition containing a tetramisole salt |
| US5284877A (en) | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkyl and alkenyl macrolides having immunosuppressive activity |
| EP0750907B1 (en) * | 1995-06-30 | 2002-03-20 | American Cyanamid Company | Stable macrolide and macrolide vaccine compositions |
| ATE252316T1 (de) * | 1996-06-05 | 2003-11-15 | Ashmont Holdings Ltd | Injizierbare zusammensetzungen |
| US6974577B2 (en) * | 2001-02-04 | 2005-12-13 | Novartris Ag | Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
| UY27412A1 (es) * | 2002-08-12 | 2003-06-30 | Carlson Internat Inc | Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn. |
| US6653288B1 (en) * | 2002-09-30 | 2003-11-25 | Virbac S.A. | Injectable anthelmintic compositions and methods for using same |
| LT1610613T (lt) * | 2003-04-04 | 2017-03-27 | Merial, Inc. | Vietinio taikymo antihelmintinės veterinarinės kompozicijos |
-
2010
- 2010-04-13 US US12/759,176 patent/US8313752B2/en active Active
- 2010-04-14 ES ES10764714.1T patent/ES2546480T3/es active Active
- 2010-04-14 BR BRPI1014571A patent/BRPI1014571B8/pt active IP Right Grant
- 2010-04-14 PL PL10764714T patent/PL2419131T3/pl unknown
- 2010-04-14 MX MX2011010710A patent/MX2011010710A/es active IP Right Grant
- 2010-04-14 EP EP10764714.1A patent/EP2419131B1/en active Active
- 2010-04-14 PT PT107647141T patent/PT2419131E/pt unknown
- 2010-04-14 AU AU2010237070A patent/AU2010237070B2/en active Active
- 2010-04-14 DK DK10764714.1T patent/DK2419131T3/en active
- 2010-04-14 WO PCT/NZ2010/000067 patent/WO2010120195A1/en not_active Ceased
- 2010-04-14 CA CA2758276A patent/CA2758276C/en active Active
-
2011
- 2011-10-11 ZA ZA2011/07324A patent/ZA201107324B/en unknown
- 2011-11-10 CO CO11152718A patent/CO6450627A2/es not_active Application Discontinuation
-
2015
- 2015-08-20 CY CY20151100729T patent/CY1116630T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI1014571B1 (pt) | 2021-08-10 |
| DK2419131T3 (en) | 2015-06-29 |
| EP2419131A4 (en) | 2013-01-09 |
| PL2419131T3 (pl) | 2015-11-30 |
| CA2758276C (en) | 2018-01-23 |
| ES2546480T3 (es) | 2015-09-24 |
| AU2010237070B2 (en) | 2015-03-26 |
| BRPI1014571B8 (pt) | 2022-06-28 |
| ZA201107324B (en) | 2012-07-25 |
| WO2010120195A1 (en) | 2010-10-21 |
| CO6450627A2 (es) | 2012-05-31 |
| CA2758276A1 (en) | 2010-10-21 |
| PT2419131E (pt) | 2015-09-28 |
| US20100266628A1 (en) | 2010-10-21 |
| EP2419131A1 (en) | 2012-02-22 |
| US8313752B2 (en) | 2012-11-20 |
| CY1116630T1 (el) | 2017-03-15 |
| EP2419131B1 (en) | 2015-06-03 |
| AU2010237070A1 (en) | 2011-11-03 |
| MX2011010710A (es) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014571A2 (pt) | composições de combinação de lactona macrocíclica, vacinas e processos para produzir as mesmas | |
| IL216826A0 (en) | Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same | |
| BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
| IL216825A0 (en) | Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof | |
| ZA201404733B (en) | Novel benzopyran compounds, compositions and uses thereof | |
| BRPI1010301A2 (pt) | composição. | |
| BR112013033811A2 (pt) | composição, método de preparação da composição, e, composto | |
| BRPI1013342A2 (pt) | conjunto de anel de turbina. | |
| BR112012004108A2 (pt) | composições de poliidroxialcanoato endurecidas | |
| LT3202460T (lt) | Arilmetoksi izoindolino dariniai ir kompozicijos, apimantys ir jų panaudojimo būdus | |
| BRPI1010617A2 (pt) | uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição. | |
| LT3795573T (lt) | Tam tikri triazolopirazinai, jų sudėtis ir jų panaudojimo būdai | |
| BRPI0909030A2 (pt) | composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. | |
| BRPI0925037A2 (pt) | Composição contendo piceatanol e método de produzir a composição contendo piceatanol. | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| HRP20150107T1 (xx) | Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola | |
| IL216832A0 (en) | Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof | |
| ZA201106045B (en) | Benzofuran derivatives | |
| BRPI1014388A2 (pt) | preparação de sólido. | |
| BRPI1007811A2 (pt) | nacela de turborreator, e, turborreator | |
| BRPI1005919A2 (pt) | composição imunogênica | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| BR112012003258A2 (pt) | Composição ativa de aroma | |
| EP2515938A4 (en) | IMMUNOGENIC COMPOSITIONS | |
| BR112012008202A2 (pt) | processo de preparação de uma composição, componentes e uso da composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
| B25G | Requested change of headquarter approved |
Owner name: MERIAL LIMITED (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: MERIAL, INC. (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US) |